MODERATOR
:
SPEAKER
(S):
Jerry Holmberg, PhD, MT(ASCP)SBB, Director, Scientific Affairs, Novartis Vaccines and Diagnotstics, Inc.
Dr. Pierre Robillard, MD, Medical Director, Hema-Quebec
Utilisation of hemovigilance data: the example of the Quebec Hemovigilance System
D. Michael Strong, PhD, MT(ASCP), Adjunct Professor, Department of Orthopaedics and Sports Medicine, University of Washington, School of Medicine
U.S. Biovigilance Network
Matthew Kuehnert, MD, Director, Office of Blood, Organ, Other Tissue Safety, Centers for Disease Control and Prevention
Jackie Fredrick, MBA, MT(ASCP)SBB, CEO, Blood Center of Wisconsin
Description
This session will offer an overview of the U.S. Biovigilance Network the history of the network, a brief overview of the public-private partnership and the potential , including accomplishments, and an outline of future goals of the network.
LEARNER OUTCOMES:
-
Convey the history and background of the U.S. Biovigilance Network, including the overall scope and goals of the network, the information that is being collected, and the reasons the network is necessary for improved patient safety and health care.
-
Describe the value of hemovigilance and how it has worked effectively in another healthcare system.
-
Describe the vision and explore the potential for the U.S. Biovigilance Network.
-
Explain the roles of each group involved in the public-private partnership so there is a clear understanding of what each contributes to the network.
CE Category | CE Value |
---|
California Clinical Laboratory Personnel |
1.5 |
California Nurse |
1.8 |
Florida Laboratory Personnel |
1.8 |
General Attendee |
1.5 |
Physician |
1.5 |
Please note: Continuing education (CE) credit is available for online offerings only. Individuals that purchase CD-ROMs will not receive CE credit for the programs they view.